Nanopharmaceutical Approaches for Inducing Cell Death in Tumors
A special issue of Nanomaterials (ISSN 2079-4991). This special issue belongs to the section "Biology and Medicines".
Deadline for manuscript submissions: 31 December 2024 | Viewed by 156
Special Issue Editors
Interests: nanomedicine; drug delivery; mechanisms of toxicology; cancer therapy; 3D cellular models
Special Issues, Collections and Topics in MDPI journals
Interests: biochemistry; nanotoxicology; 3D cell culture; drug delivery; cancer cell death mechanisms; micro-/nano-plastic toxicity
Special Issue Information
Dear Colleagues,
The evolving field of nanopharmaceuticals presents significant potential for innovation in the targeted treatment of tumors, especially through the induction of cell death. This Special Issue of Nanomaterials explores the latest advancements in nanopharmaceutical approaches designed to induce apoptosis or other forms of cell death, such as necrosis, autophagy, pyroptosis, ferroptosis, necroptosis, PANoptosis, etc., in cancerous cells. Emphasizing original strategies, this issue addresses the development and application of various nanomaterials, including nanoparticles, nanocarriers, and nanosystems, engineered to deliver therapeutic agents to tumor sites with high efficacy, thereby promoting cancer cell death and tumor suppression. Contributions also delve into the molecular mechanisms by which nanopharmaceuticals induce cell death, offering insights into their interactions with cellular pathways and their potential to overcome drug resistance.
Through a collection of original research articles and reviews, this Special Issue aims to provide a comprehensive overview of the state of the art in nanopharmaceuticals for tumor therapy. Moreover, it highlights the clinical potential of these advanced materials, addressing both current challenges and promising directions for future research. By focusing on the intricate interplay between nanotechnology and cellular processes, this issue aspires to pave the way for novel, more effective cancer treatments.
Dr. Mihaela Balas
Guest Editor
Dr. Madalina Andreea Badea
Guest Editor Assistant
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nanomaterials is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanoparticles
- cell death
- anti-tumoral mechanisms
- targeted cancer therapy
- drug delivery
- cancer treatment
- selective toxicity
- oncogenic signaling pathways
- drug resistance
